Overview
Analysis
CPRZ5059828 analysis
Key facts
Cheplapharm Arzneimittel GmbH engages in the development and manufacture of pharmaceutical products. The firm offers medicinal products for sleeping disorders, leukemia, hepatobiliary disorders, alcohol withdrawal, and connective tissue disorders. The company was founded by Kurt Teubner in 1998 and is headquartered in Greifswald, Germany.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.